News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded relea ...

The location of the devitalized tissue also affects amputation risk, healing potential, and quality of life. Dosluoglu et al confirmed we anecdotally know that necrotic heel ulcerations do poorly, and ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s M ...

Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...